Kymera Therapeutics Inc (KYMR) Ownership

40.89 ↑0.66 (1.64%)

As of December 31, 1969, 7:00pm EST.

Institutions
Mutual Funds

Institutional Ownership

T. Rowe Price Associates, Inc. is the biggest individual institutional holder of Kymera Therapeutics Inc (KYMR), owning a total of 6.6 million shares. Combined, the top 36 institutional holders of KYMR own 102.74% of the company with a total of 65.7 million shares.

In the latest ownership report on September 30th 2024, the top 36 institutional holders increased their combined ownership of KYMR by 1.3 million shares. 11 institutions bought 3,554,209 total additional shares and increased their ownership by an average of 58.37%. However 7 institutions sold 2,227,872 total shares and decreased their ownership by an average of 22.01%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Kymera Therapeutics increased by a net total of 1,326,337 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
T. Rowe Price Associates, Inc.	10.261%	3.987%	6,645,474	254,816	2024-09-30
Baker Bros Advisors LP	9.258%	0.000%	5,995,929	1	2024-09-30
Bvf Inc	7.970%	0.000%	5,161,801	0	2024-09-30
FMR Inc	7.889%	5.849%	5,109,141	282,301	2024-09-30
Vanguard Group Inc	7.340%	-1.424%	4,753,766	-68,650	2024-09-30
Wellington Management Company LLP	7.131%	7.169%	4,618,359	308,954	2024-09-30
venBio Select Advisor LLC	6.948%	15.714%	4,500,000	611,112	2024-09-30
State Street Corp	2.668%	-9.554%	1,728,144	-182,547	2024-09-30
Redmile Group, LLC	2.151%	-11.779%	1,393,256	-186,019	2024-09-30
Driehaus Capital Management LLC	2.052%	494.729%	1,328,703	1,105,290	2024-09-30
Geode Capital Management, LLC	1.626%	-0.095%	1,053,224	-996	2024-09-30
Rock Springs Capital Management LP	1.620%	-9.845%	1,049,386	-114,587	2024-09-30
Jennison Associates LLC	1.232%	85.815%	797,681	368,394	2024-09-30
Deep Track Capital, LP	0.927%	-59.978%	600,326	-899,674	2024-09-30
Woodline Partners LP	0.811%	1.409%	525,094	7,297	2024-09-30
Eventide Asset Management, LLC	0.784%	9.912%	507,902	45,803	2024-09-30
Avidity Partners Management LP	0.772%	0.000%	500,000	500,000	2024-09-30
Morgan Stanley - Brokerage Accounts	0.754%	-61.370%	488,077	-775,399	2024-09-30
Dimensional Fund Advisors, Inc.	0.730%	17.456%	472,626	70,241	2024-09-30

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
T. Rowe Price Associates, Inc.	10.261%	3.987%	6,645,474	254,816	2024-09-30
Baker Bros Advisors LP	9.258%	0.000%	5,995,929	1	2024-09-30
Bvf Inc	7.970%	0.000%	5,161,801	0	2024-09-30
FMR Inc	7.889%	5.849%	5,109,141	282,301	2024-09-30
Vanguard Group Inc	7.340%	-1.424%	4,753,766	-68,650	2024-09-30
Wellington Management Company LLP	7.131%	7.169%	4,618,359	308,954	2024-09-30
venBio Select Advisor LLC	6.948%	15.714%	4,500,000	611,112	2024-09-30
BlackRock Inc	6.416%	13.671%	4,155,429	499,769	2024-06-30
Artal Group S A	4.641%	-0.711%	3,005,610	-21,525	2024-06-30
State Street Corporation	4.138%	41.084%	2,672,518	778,239	2024-03-31
State Street Corp	2.668%	-9.554%	1,728,144	-182,547	2024-09-30
Redmile Group, LLC	2.151%	-11.779%	1,393,256	-186,019	2024-09-30
Driehaus Capital Management LLC	2.052%	494.729%	1,328,703	1,105,290	2024-09-30
T. Rowe Price Investment Management,Inc.	2.112%	-19.531%	1,295,943	-314,553	2023-12-31
Geode Capital Management, LLC	1.626%	-0.095%	1,053,224	-996	2024-09-30
Rock Springs Capital Management LP	1.620%	-9.845%	1,049,386	-114,587	2024-09-30
Bank of New York Mellon Corp	1.747%	-2.424%	965,967	-23,999	2023-03-31
Aquilo Capital Management, LLC	1.436%	12.671%	881,337	99,118	2023-12-31
Jennison Associates LLC	1.232%	85.815%	797,681	368,394	2024-09-30
EcoR1 Capital, LLC	1.437%	0.000%	796,093	0	2023-03-31
Deep Track Capital, LP	0.927%	-59.978%	600,326	-899,674	2024-09-30
Marshall Wace Asset Management Ltd	0.934%	0.000%	572,926	572,926	2024-03-31
Wasatch Advisors Inc.	1.033%	-52.232%	572,907	-626,443	2023-09-30
Woodline Partners LP	0.811%	1.409%	525,094	7,297	2024-09-30
Eventide Asset Management, LLC	0.784%	9.912%	507,902	45,803	2024-09-30
NORGES BANK	0.822%	127.047%	504,083	282,066	2023-12-31
Avidity Partners Management LP	0.772%	0.000%	500,000	500,000	2024-09-30
Candriam Luxembourg S.C.A.	0.823%	0.000%	488,306	0	2023-09-30
Morgan Stanley - Brokerage Accounts	0.754%	-61.370%	488,077	-775,399	2024-09-30
Dimensional Fund Advisors, Inc.	0.730%	17.456%	472,626	70,241	2024-09-30
Massachusetts Financial Services Company	0.754%	-0.185%	462,675	-858	2023-12-31
Goldman Sachs Group Inc	0.714%	2.617%	462,309	11,791	2024-06-30
AJU IB Investment Co Ltd	0.828%	0.000%	457,059	0	2022-09-30
JPMorgan Chase & Co	0.706%	-10.993%	455,936	-56,310	2024-03-31
UBS Asset Mgmt Americas Inc	0.670%	140.957%	433,573	253,635	2024-06-30
Northern Trust Corp	0.605%	-0.492%	331,738	-1,640	2022-09-30

Mutual Fund Ownership

US Small-Cap Growth II Equity Comp is the biggest individual fund holder of Kymera Therapeutics Inc (KYMR), owning a total of 3.1 million shares. Combined, the top 41 mutual fund holders of KYMR own 55.22% of the company with a total of 34.7 million shares.

In the latest ownership report on November 30th 2024, the top 41 fund holders increased their combined ownership of KYMR by 18 thousand shares. 4 funds bought 25,153 total additional shares and increased their ownership by an average of 0.80%. However 1 funds sold 7,312 total shares and decreased their ownership by an average of 0.48%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Kymera Therapeutics increased by a net total of 17,841 in the latest report.

Mutual Funds Chart

Latest Mutual Fund Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Vanguard Total Stock Mkt Idx Inv	2.358%	-0.477%	1,527,129	-7,312	2024-11-30
iShares Russell 2000 ETF	1.950%	0.000%	1,263,138	0	2024-11-30
Vanguard Small Cap Index	1.880%	0.589%	1,217,312	7,129	2024-11-30
SPDR® S&P Biotech ETF	1.103%	1.443%	714,536	10,164	2024-11-30
Vanguard Institutional Extnd Mkt Idx Tr	1.039%	0.526%	672,610	3,520	2024-11-30
Vanguard Small Cap Growth Index Inv	1.034%	0.653%	669,324	4,340	2024-11-30

Top Mutual Funds

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
US Small-Cap Growth II Equity Comp	4.850%	5.414%	3,140,871	161,323	2024-09-30
T. Rowe Price New Horizons	4.847%	-0.065%	3,138,832	-2,039	2024-10-31
Fidelity Growth Compy Commingled Pl S	3.496%	0.715%	2,264,231	16,068	2024-10-31
Fidelity Growth Compy Commingled Pl O	3.462%	2.409%	2,235,816	52,597	2024-08-31
Vanguard Health Care Inv	2.819%	26.192%	1,825,706	378,942	2024-09-30
Fidelity Growth Company Fund	2.548%	0.000%	1,650,239	0	2024-10-31
Vanguard Total Stock Mkt Idx Inv	2.358%	-0.477%	1,527,129	-7,312	2024-11-30
iShares Russell 2000 ETF	1.950%	0.000%	1,263,138	0	2024-11-30
Vanguard Small Cap Index	1.880%	0.589%	1,217,312	7,129	2024-11-30
Vanguard Instl Ttl Stck Mkt Idx Tr	2.156%	-0.117%	1,196,248	-1,399	2023-03-31
T. Rowe Price Health Sciences	1.845%	-0.106%	1,195,043	-1,263	2024-10-31
Vanguard Explorer Inv	1.349%	-18.761%	873,677	-201,761	2024-09-30
T. Rowe Price New Horizons Tr-Z	1.153%	18.040%	746,611	114,105	2024-09-30
SPDR® S&P Biotech ETF	1.103%	1.443%	714,536	10,164	2024-11-30
Vanguard Institutional Extnd Mkt Idx Tr	1.039%	0.526%	672,610	3,520	2024-11-30
Vanguard Small Cap Growth Index Inv	1.034%	0.653%	669,324	4,340	2024-11-30
T. Rowe Price Integrated US SmCapGrEq	0.881%	-2.501%	570,774	-14,639	2024-09-30
T. Rowe Price Integrated US Sm Gr Eq	0.881%	0.000%	570,774	0	2024-10-31
Vanguard Extended Market Index Investor	0.973%	-0.020%	539,225	-110	2023-08-31
BNY Mellon Sm/Md Cp Gr I	0.967%	-2.257%	534,574	-12,346	2023-04-30
Fidelity® Select Biotechnology	0.959%	-26.700%	532,313	-193,900	2023-11-30
Eventide Healthcare & Life Sciences I	0.784%	9.912%	507,902	45,803	2024-09-30
Fidelity Growth Company K6	0.767%	-3.135%	496,427	-16,068	2024-10-31
UBS: US Equity Small Cap Growth	0.746%	20.475%	483,231	82,126	2024-06-30
Fidelity Select Biotechnology	0.743%	-21.590%	456,141	-125,600	2024-05-31
Fidelity Small Cap Index	0.700%	-0.485%	453,420	-2,211	2024-09-30
PGIM Jennison Health Sciences Z	0.641%	84.072%	414,023	189,099	2024-08-31
Fidelity Series Growth Company	0.628%	6.152%	405,500	23,500	2024-07-31
T. Rowe Price Small-Cap Value	0.682%	-36.098%	404,853	-228,700	2023-12-31
iShares Biotechnology ETF	0.655%	-0.834%	403,330	-3,393	2024-07-31
iShares Russell 2000 Growth ETF	0.649%	-0.236%	399,472	-944	2024-07-31
iShares Russell 2000 Value ETF	0.689%	0.561%	380,864	2,124	2023-06-21
Fidelity® Small Cap Index	0.663%	3.225%	367,982	11,495	2023-10-31
TRP Integrated US Small-Cap Gr Eq	0.641%	23.080%	355,700	66,700	2023-09-30
Belfius Equities Cure C Cap	0.570%	0.000%	312,815	0	2022-10-31
Candriam Global Equities Oncology	0.570%	37.493%	312,815	85,302	2022-09-30
T. Rowe Price U.S. SC Value Eq Tr-Z	0.549%	0.066%	304,345	200	2023-09-30
DFA US Micro Cap I	0.536%	6.722%	296,258	18,659	2023-05-31
Pictet-Biotech P USD	0.530%	-16.959%	290,858	-59,401	2022-07-31
Wellington Global Hlthcr Eq USD G Ac	0.460%	41.092%	281,022	81,845	2024-01-31
MFS New Discovery I	0.469%	0.000%	278,525	0	2023-12-31